Aapka Bazaar: Investors' Query On Walchand Nagar, Cairn India and Lupin
Our Zee Business viewers call us on our daily show to ask their investment related queries. Today our caller asked us their query related to Walchand Nagar, Cairn India and Lupin
Dec 15, 2015, 13:46 PM IST
Lupin appoints Martin Mercer as head of Latin American biz
Drug major Lupin Monday appointed Martin Mercer as President of its Latin American business with immediate effect.
Oct 26, 2015, 18:21 PM IST
Lupin, Boehringer Ingelheim to co-market linagliptin in India
Drug majors Lupin and Boehringer Ingelheim on Wednesday announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.
Oct 14, 2015, 12:04 PM IST
India drugmaker stocks exception in Asian rout
In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.
Sep 03, 2015, 19:37 PM IST
Lupin gets shareholders nod to raise up to Rs 7,500 crore
Drug major Lupin on Saturday said it has received approval from its shareholders to raise up to Rs 7,500 crore through issue of securities.
Jul 25, 2015, 19:33 PM IST
Lupin Q1 net dips by 16% at Rs 525.02 cr
The company had posted a net profit after taxes and minority interest of Rs 624.74 crore for the corresponding period of the previous fiscal, Lupin said in a filing to BSE.
Jul 23, 2015, 16:08 PM IST
Brazil suspends import of Lupin's antibiotic ingredients
Brazilian drug regulator ANVISA has suspended import of active ingredients produced by pharma major Lupin used to make antibiotics, citing "unsatisfactory inputs" and deviation from good manufacturing practices (GMP).
Jul 07, 2015, 20:42 PM IST
Stocks markets head for 2-1/2-month closing high; HDFC Bank, Lupin lead
India`s stock markets rose on Friday to head towards their highest close in 2-1/2 months as HDFC Bank Ltd rose on relative valuations, while drugmaker Lupin Ltd rose after an acquisition in Russia.
Jul 03, 2015, 13:47 PM IST
Lupin up 2.5% on Russia's Biocom acquisition
Shares of drug major Lupin on Friday gained 2.5 percent after the company announced acquisition of Russia's Biocom, marking its foray into the Russian pharma market, which is expected to be one of the top eight in the world by 2018.
Jul 03, 2015, 13:43 PM IST
Lupin acquires Russian drug firm Biocom
The company has acquired 100 per cent equity stake in ZAO Biocom in Russia subject to certain closing conditions, Lupin Ltd said in a statement without disclosing the financial details.
Jul 02, 2015, 19:49 PM IST
Lupin to beef up branded portfolio through alliances
"In 2015-16, the company remains committed to continuing to strengthen its branded portfolio with the launch of additional products by not only creating alliances but also developing its own pipeline and making strategic brand acquisitions in US markets," Lupin said in its annual report here.
Jun 28, 2015, 15:51 PM IST
Lupin gets Board's nod to raise funds up to Rs 7,500 crore
Drug major Lupin on Tuesday said its Board of Directors have given in-principle approval for raising funds of up to Rs 7,500 crore.
Jun 23, 2015, 10:56 AM IST
Lupin shares gain on inclusion in Sensex
Shares of drugmaker Lupin rose by almost 2 percent after the stock became part of the BSE benchmark Sensex from on Monday.
Jun 22, 2015, 13:16 PM IST
Lupin to replace Tata Power on Sensex from Monday
Besides, a host of changes would also be effective in various other indices, where Adani Power would be dropped from the BSE 100 index.
Jun 21, 2015, 12:18 PM IST
Lupin submits fresh studies for two products suspended by EMA
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
May 26, 2015, 14:10 PM IST
BSE drops Tata Power from Sensex; Lupin to come in
Private sector electricity producer Tata Power will move out of the stock market benchmark index Sensex and will be replaced by drugmaker Lupin.
May 22, 2015, 19:31 PM IST
Lupin acquires Brazilian drug firm Medquimica
Drug major Lupin Wednesday announced acquisition of Brazil's Medquimica Industria Farmaceutica SA, marking its foray into the Latin American nation.
May 13, 2015, 21:31 PM IST
Lupin launches anti-bacterial Zaxine tablets in Canada
Zaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis).
Apr 20, 2015, 14:17 PM IST
Lupin to acquire additional 40% stake in SA's Pharma Dynamics
Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.
Mar 16, 2015, 15:24 PM IST
Lupin gets USFDA nod for ophthalmic solution
The company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from the US Food and Drug Administration (USFDA).
Feb 23, 2015, 15:42 PM IST
